Stock Updates

Is this Large Market Cap Stock target price reasonable for Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ)?

The company in question is, Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) currently with a stock price of 119.94 (-0.97% today). The market cap for Jazz Pharmaceuticals Public Limited Company is 7337.45, and is in the sector Healthcare, and Biotechnology industry. The target price for Jazz Pharmaceuticals Public Limited Company is 183.25. Currently Jazz Pharmaceuticals Public Limited Company is trading with a P/E of 21.27, and a forward P/E of 10.49. Average volume for Jazz Pharmaceuticals Public Limited Company is 663.88 and so far today it is 127818.

Performance in the last year for Jazz Pharmaceuticals Public Limited Company has been -8.64%. For EPS growth, Jazz Pharmaceuticals Public Limited Company has seen a growth of 460.60%, and is looking to grow in the next year to 15.84%. More long term stats show that EPS growth has been 44.40% over the last five years and could be 18.03% for the next five years. Jazz Pharmaceuticals Public Limited Company has seen sales growth quarter over quarter at 14.20%, with EPS growth quarter over quarter at 28.90%. The 20-day simple moving average is -6.80%, with the 200-day simple moving average coming to -11.30%.

Since the IPO date for Jazz Pharmaceuticals Public Limited Company on the 06/01/2007, Jazz Pharmaceuticals Public Limited Company has seen performance year to date to be -13.83%. With Jazz Pharmaceuticals Public Limited Company trading at 119.94, the dividend yield is *TBA, and the EPS is 5.69.

So could Jazz Pharmaceuticals Public Limited Company, be undervalued? Well as said before P/E is 21.27. The PEG is 1.18, P/S is 5.25 and the P/B is at 4.33. The P/cash is 8.01, with P/free cash flow at 18.5.

Jazz Pharmaceuticals Public Limited Company ability to deal with debt shows that the current ratio is 5.4, and the quick ratio is 5.3. This is with long term debt/equity at 0.67, and total debt/equity at 0.7.

In terms of margins, Jazz Pharmaceuticals Public Limited Company has a gross margin of 92.90%, an operating margin of 37.80% and a profit margin of 25.50%.Payout ratio for Jazz Pharmaceuticals Public Limited Company is 0.00%. Return on assets come to 10.30% with return on investment coming to 13.80%.

Insider ownership for Jazz Pharmaceuticals Public Limited Company, is at 2.70% and institutional ownership comes to 92.00%. Outstanding shares are at 60.58. While shares float is 59.13. The float short is currently 3.26%, and short ratio is 2.91.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment